Merit Medical touts positive six-month data from WAVE trial [Yahoo! Finance]
Merit Medical Systems, Inc. (MMSI)
Last merit medical systems, inc. earnings: 4/23 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
merit.com/investors
Company Research
Source: Yahoo! Finance
Merit Medical has revealed positive six-month data from a trial investigating its endoprosthesis in dialysis patients who require an arteriovenous fistula (AVF). The results, which were presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), demonstrate that the US company's device led to an 89.9% target lesion primary patency at six months. Merit Medical's device, named WRAPSODY, is a cell-impermeable stent graft designed to extend long-term vessel patency in dialysis patients. AVFs are abnormal connections created between arteries and veins for dialysis access. For patients undergoing multiple haemodialysis procedures, repeated blockages can occur. The WRASODY arteriovenous access efficacy (WAVE) trial enrolled 245 patients, with patients either receiving Merit's treatment or percutaneous transluminal angioplasty (PTA), the standard-of-care. Merit reported that target lesion primary patency in patients treated with WRAPSODY was 27 percenta
Show less
Read more
Impact Snapshot
Event Time:
MMSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MMSI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MMSI alerts
High impacting Merit Medical Systems, Inc. news events
Weekly update
A roundup of the hottest topics
MMSI
News
- Merit Medical Systems, Inc. (NASDAQ: MMSI) had its price target raised by analysts at Barrington Research from $100.00 to $114.00. They now have an "outperform" rating on the stock.MarketBeat
- Merit Medical Systems, Inc. (NASDAQ: MMSI) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Merit Medical Stock Falls Despite Positive WRAPSODY Trial Results [Yahoo! Finance]Yahoo! Finance
- Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
- Merit Medical Systems - Impressive Momentum [Seeking Alpha]Seeking Alpha
MMSI
Earnings
- 8/1/24 - Beat
MMSI
Sec Filings
- 9/18/24 - Form 8-K
- 8/29/24 - Form S-8
- 8/1/24 - Form 10-Q
- MMSI's page on the SEC website